← Back to Search

Aerobic Activity for Cognitive Disorders (CogEx Trial)

N/A
Waitlist Available
Led By John M. Jakicic, PhD
Research Sponsored by University of Pittsburgh
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 3 months, 6 months, 12 months
Awards & highlights

CogEx Trial Summary

This trial will look at how different types of exercise affect brain health in older adults.

Eligible Conditions
  • Cognitive Disorders
  • Brain Pathology
  • Physical Disabilities
  • Physical Activity
  • Aging

CogEx Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 3 months, 6 months, 12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 3 months, 6 months, 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change from Baseline Brain Structure at 6 and 12 months
Secondary outcome measures
Change from Baseline Auditory Verbal Learning Test at 3, 6, and 12 months
Change from Baseline Fitness at 3, 6, and 12 months
Change from Baseline Functional Fitness at 3, 6, and 12 months
+5 more
Other outcome measures
Change from Baseline Height in centimeters at 3, 6, and 12 months
Change from Baseline Mood at 3, 6, and 12 months
Change from Baseline Physical Activity Barriers at 3, 6, and 12 months
+7 more

CogEx Trial Design

4Treatment groups
Experimental Treatment
Group I: YogaExperimental Treatment1 Intervention
Yoga involves a series of movements and poses that are performed in a specific sequence that are adapted to your ability, with activity progressing to 150 minutes per week. This will require the participant to attend one supervised session each week for a period of 12 months with the remaining sessions being performed on their own without supervision.
Group II: Resistance TrainingExperimental Treatment1 Intervention
Resistance exercise that involves participating in activities similar to lifting weights that cause the participant to work specific muscles of your body, with activity progressing to 150 minutes per week. This can involve using weight training machines, elastic tubes that create resistance, or weights such a dumbbells. This will require the participant to attend one supervised session each week for a period of 12 months with the remaining sessions being performed on their own without supervision.
Group III: Health EducationExperimental Treatment1 Intervention
This involves the participant receiving information regarding aspects of health that are important for older adults, and also physical activity in the form of light stretching activities and movements. This will require the participant to attend one supervised session each week for a period of 12 months with the remaining sessions being performed on their own without supervision.
Group IV: Aerobic ActivityExperimental Treatment1 Intervention
Moderate-intensity exercise aerobic exercise that involves participating in activities similar to brisk walking that increase heart rate and breathing rate, with activity progressing to 150 minutes per week. Activities other than brisk walking, such as dance, aerobics, swimming, cycling or other activities that increase heart rate and breathing rate to a moderate intensity that can be sustained for at least 10 minutes will also be encouraged. This will require the participant to attend one supervised session each week for a period of 12 months with the remaining sessions being performed on their own without supervision.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Yoga
2008
Completed Phase 3
~3830
Health Education
2014
Completed Phase 3
~4010
Resistance Training
2019
Completed Phase 2
~1190

Find a Location

Who is running the clinical trial?

University of PittsburghLead Sponsor
1,722 Previous Clinical Trials
16,342,858 Total Patients Enrolled
1 Trials studying Cognitive Disorders
22 Patients Enrolled for Cognitive Disorders
John M. Jakicic, PhDPrincipal Investigator - University of Pittsburgh
University of Pittsburgh
3 Previous Clinical Trials
797 Total Patients Enrolled
Fabrisia Ambrosio, PhDPrincipal InvestigatorUniversity of Pittsburgh

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this research seeking participants of at least twenty years in age?

"The age constraints for this medical experiment stipulate that the youngest enrollee must be at least 65 years old and the oldest can not exceed 80."

Answered by AI

To whom does this research study extend its eligibility?

"To qualify for this research study, applicants must meet the pre-defined eligibility criteria and be between 65 to 80 years old. The team needs a total of 150 participants in order to complete the trial."

Answered by AI

Are there any available vacancies for participants in this research?

"Per the details on clinicaltrials.gov, this trial is not actively recruiting participants at present. Initially posted in September 2018 and last updated February 2022, it has yet to initiate patient enrollment; however, 443 other trials are seeking volunteers right now."

Answered by AI
~12 spots leftby Apr 2025